Skip to main content

Sana Biotechnology, Inc.

SANA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001770121

No open-market purchases or sales by Sana Biotechnology, Inc. insiders were filed in the last 90 days; 211 institutions reported holding it in 13F filings for Q2 2026, worth $644.7M in total; no superinvestor holds it.

Q2 2023 vs. Q1 2023

How the institutions holding Sana Biotechnology, Inc. changed between Q1 2023 and Q2 2023.

All holders in Q2 2023All holders in Q1 2023

13F holders of SANA: Q1 2023 compared with Q2 2023
MeasureQ1 2023Q2 2023Change
Holders120123+3
Shares130.7M134.9M+4.23M (+3.2%)
Value$427.4M$804.1M+$376.7M (+88.1%)

New holders (13)

Institutions that held Sana Biotechnology, Inc. at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to SANA in Q2 2023
InstitutionSharesValue% of portfolio
Capital World Investors1,531,307$9.13M0.00%
Casdin Capital, LLC750,000$4.47M0.39%
Voloridge Investment Management, LLC106,226$633.1K0.00%
Marshall Wace, LLP87,629$522.3K0.00%
Franklin Resources Inc44,112$262.9K0.00%
LPL Financial LLC20,625$122.9K0.00%
Advisory Research Inc19,806$118.0K0.02%
Sculptor Capital LP19,400$115.6K0.00%
Aigen Investment Management, LP13,171$78.5K0.01%
Sherbrooke Park Advisers LLC12,800$76.3K0.04%
Red Tortoise LLC437$2.60K0.00%
Allworth Financial LP33$1970.00%
Parallel Advisors, LLC27$1610.00%

Sold out (10)

Institutions that held Sana Biotechnology, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.

Institutions that sold out of SANA in Q2 2023
InstitutionShares, Q1 2023Value, Q1 2023
Gsa Capital Partners LLP265,372$868.0K
Jump Financial, LLC89,700$293.3K
Renaissance Technologies LLC61,100$200.0K
Dark Forest Capital Management LP22,564$73.8K
Cubist Systematic Strategies, LLC20,294$66.4K
Caxton Associates LP15,639$51.1K
Handelsbanken Fonder AB12,200$40.0K
Quantbot Technologies LP7,500$24.5K
US Bancorp4,202$13.7K
Advisor Group Holdings, Inc.513$1.68K